Sector portfolio · VC firm · Japan

Global Brain Corporation's Biotech portfolio

Global Brain Corporation has backed 14 Biotech startups in rounds we track, $661M between them, shown by the stage each has reached. The best-funded is Bit.Bio.

14startups backed
4stages
$661Mraised between them
Stage not reportedbiggest stage

Global Brain Corporation's whole portfolioGlobal Brain Corporation's profile

Stage not reported

6

Series A

3

Series C and later

3

Series B

2

Segment by segment

Stage not reported

6 startups · $180M raised

  1. HHealxUnited Kingdom$66M
  2. Metaphore BiotechnologiesMetaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.United States$50M
  3. ChromaCodeChromaCode is a molecular diagnostics company focusing on bioinformatics.United States$44M
  4. MedRhythmsMedrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.United States$9.6M
  5. EditForce九州大学発のRNA編集技術にもとづく創薬開発をおこなう、エディットフォース株式会社。独自のRNA編集技術を活用し、医療、産業、農業などの様々な分野において新たな世界標準をつくります。Japan$7.3M
  6. VisolisVisolis, a bioengineering company, develops carbon-negative and sustainable chemicals.United States$2.9M

Series A

3 startups · $166M raised

  1. GC TherapeuticsGC Therapeutics (GCTx) is a biopharmaceutical and biotechnology company based in Cambridge, Massachusetts, founded in 2019.United States$65M
  2. Switch TherapeuticsSwitch Therapeutics is a preclinical-stage biotechnology company founded in 2020, focused on developing innovative RNA interferencUnited States$52M
  3. Shoulder InnovationsShoulder Innovations is a medical device company that develops inset glenoid fixation technology.United States$49M

Series C and later

3 startups · $290M raised

  1. bit.biobit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom.United Kingdom$264M
  2. ThinkCyteThinkCyte is a biotechnology company founded in 2016, specializing in AI-based cell analysis, characterization, and sorting technologies.Japan$15M
  3. Siolta TherapeuticsSiolta Therapeutics, Inc.United States$12M

Series B

2 startups · $25M raised

  1. Rege NephroRege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.Japan$15M
  2. AAwairUnited States$10M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Global Brain Corporation as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioGlobal Brain Corporation's AI portfolio39 startups · $1.4BSector portfolioGlobal Brain Corporation's Consumer Apps portfolio14 startups · $316MSector portfolioGlobal Brain Corporation's Fintech portfolio12 startups · $232MPortfolio mapGlobal Brain Corporation portfolio map147 startups · $5.9BCo-investorsWho invests with Global Brain Corporation144 co-investorsInvestments abroadGlobal Brain Corporation's investments in the United States44 startups · $1.5B

Raising from investors like Global Brain Corporation?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps